The historical rank and industry rank for Spectral AI's Gross Margin % or its related term are showing as below:
MDAI'
s Gross Margin % Range Over the Past 10 Years
Min: 42.72 Med: 43.64 Max: 46.28
Current: 44.11
During the past 3 years, the highestGross Margin % of Spectral AI was 46.28%. The lowest was 42.72%. And the median was 43.64%.
MDAI's Gross Margin % is ranked worse than 62.69% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 53.335
vs MDAI: 44.11
Spectral AI had a gross margin of 46.08% for the quarter that ended in Dec. 2023 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Spectral AI was 0.00% per year.
Spectral AI Gross Margin % Historical Data
The historical data trend for Spectral AI's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Spectral AI's Gross Margin %
For the Medical Devices subindustry, Spectral AI's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spectral AI's Gross Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spectral AI's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Spectral AI's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Spectral AI (NAS:MDAI) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Spectral AI had a gross margin of 46.08% for the quarter that ended in Dec. 2023 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Spectral AI Gross Margin % Related Terms
Thank you for viewing the detailed overview of Spectral AI's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely and informed decision regarding the treatment of the patient's wound.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDAI has been successfully added to your